ES2078922T3 - Derivados de cicloheteroetanoantraceno dihetero nitrogenados utiles como agentes antipsicoticos. - Google Patents

Derivados de cicloheteroetanoantraceno dihetero nitrogenados utiles como agentes antipsicoticos.

Info

Publication number
ES2078922T3
ES2078922T3 ES90112113T ES90112113T ES2078922T3 ES 2078922 T3 ES2078922 T3 ES 2078922T3 ES 90112113 T ES90112113 T ES 90112113T ES 90112113 T ES90112113 T ES 90112113T ES 2078922 T3 ES2078922 T3 ES 2078922T3
Authority
ES
Spain
Prior art keywords
hydrido
phenyl
loweralkyl
benzyl
halo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90112113T
Other languages
English (en)
Inventor
Nancy M Gray
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GD Searle LLC
Original Assignee
GD Searle LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GD Searle LLC filed Critical GD Searle LLC
Application granted granted Critical
Publication of ES2078922T3 publication Critical patent/ES2078922T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
    • C07D295/03—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/56—Ring systems containing bridged rings
    • C07C2603/86—Ring systems containing bridged rings containing four rings
    • C07C2603/88—Ethanoanthracenes; Hydrogenated ethanoanthracenes

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Fodder In General (AREA)

Abstract

SE DESCRIBE UNA CLASE DE DERIVADOS DE ETANOANTRACENO QUE TIENEN USO EN EL TRATAMIENTO DE ENFERMEDADES DEL SISTEMA NERVIOSO CENTRAL, TALES COMO ENFERMEDADES SICOTICOS, CONVULSIVAS O DISTONICAS. LOS COMPUESTOS PARTICULARMENTE INTERESANTES SON LOS DE LA FORMULA (I), EN LA QUE CADA R5 Y R6 SE SELECCIONA INDEPENDIENTE DE HIDRIDO, ALQUIL INFERIOR, BENZIL Y FENIL; CADA UNA DE ENTRE R7 Y R11 SE SELECCIONA INDEPENDIENTEMENTE ENTRE HIDRIDO, ALQUIL INFERIOR, HIDROXIDO, BENZIL, FENIL, ALCOXIDO INFERIOR, FENOXIDO, BENZILOXIDO, HALO Y ALQUIL INFERIOR DE HALO; R12 PUEDE SELECCIONARSE ENTRE HIDRIDO, ALQUIL INFERIOR, CICLOALQUIL DE ENTRE 5 Y 6 ATOMOS DE CARBONO, CICLOALQUIL DE ENTRE 6 Y 7 ATOMOS DE CARBONO, FENIL, ALQUIL INFERIOR DE HIDROXIL, Y HETEROARIL SELECCIONADO ENTRE ANILLOS HETEROCICLICOS SATURADOS O COMPLETAMENTE INSATURADOS QUE CONTENGAN ENTRE 5 Y 7 MIEMBROS DE ANILLO DE LOS CUALES 1 O 2 MIEMBROS DEL ANILLO SON ATOMOS DE NITROGENO; CADA Y ES INDEPENDIENTEMENTE UNO O MAS GRUPOS SELECCIONADOS ENTRE HIDRIDO, HIDROXIDO, ALQUIL INFERIOR, BENZIL, FENIL, ALCOXIDO INFERIOR, FENOXIDO, ALQUIL INFERIOR DE HALO, HALO Y ALCANOIL INFERIOR; Y CADA UNA DE ENTRE R13 Y R20 SE SELECCIONA INDEPENDIENTEMENTE ENTRE HIDRIDO, ALQUIL INFERIOR, BENZIL, FENIL Y HALO; Y EN LA QUE R12 JUNTO CON UNA DE ENTRE R13, R14, R 19 O R20 PUEDE FORMAR UN ANILLO HETEROCICLICO FUNDIDO CONTENIENDO 5 O 6 MIEMBROS DE ANILLO; TAMBIEN SE PRESENTAN LAS SALES FARMACEUTICAMENTE ACEPTABLES DE DICHOS COMPUESTOS.
ES90112113T 1989-06-29 1990-06-26 Derivados de cicloheteroetanoantraceno dihetero nitrogenados utiles como agentes antipsicoticos. Expired - Lifetime ES2078922T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US37431889A 1989-06-29 1989-06-29

Publications (1)

Publication Number Publication Date
ES2078922T3 true ES2078922T3 (es) 1996-01-01

Family

ID=23476259

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90112113T Expired - Lifetime ES2078922T3 (es) 1989-06-29 1990-06-26 Derivados de cicloheteroetanoantraceno dihetero nitrogenados utiles como agentes antipsicoticos.

Country Status (10)

Country Link
EP (1) EP0405436B1 (es)
JP (1) JPH03115269A (es)
AT (1) ATE130296T1 (es)
CA (1) CA2019768A1 (es)
DE (1) DE69023557T2 (es)
DK (1) DK0405436T3 (es)
ES (1) ES2078922T3 (es)
GR (1) GR3018180T3 (es)
IE (1) IE902331A1 (es)
PT (1) PT94513B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004009017A2 (en) 2002-07-18 2004-01-29 Bristol-Myers Squibb Company Modulators of the glucocorticoid receptor and method
US7273881B2 (en) 2004-01-16 2007-09-25 Bristol-Myers Squibb Company Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
US7605264B2 (en) 2004-01-16 2009-10-20 Bristol-Myers Squibb Company Heterocyclic modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
US7253283B2 (en) 2004-01-16 2007-08-07 Bristol-Myers Squibb Company Tricyclic modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
US7625921B2 (en) 2004-01-16 2009-12-01 Bristol-Myers Squibb Company Modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
US7569689B2 (en) 2004-01-16 2009-08-04 Bristol-Myers Squibb Company Modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
US7326728B2 (en) 2004-01-16 2008-02-05 Bristol-Myers Squibb Company Modulators of glucocorticoid receptor, AP-1, and/or NF-κβ activity and use thereof
US7361654B2 (en) 2005-01-13 2008-04-22 Bristol-Myers Squibb Co. Substituted heteroaryl amide modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
US7317024B2 (en) 2005-01-13 2008-01-08 Bristol-Myers Squibb Co. Heterocyclic modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
US7411071B2 (en) 2005-01-13 2008-08-12 Bristol-Myers Squibb Company Modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
US7642273B2 (en) 2005-01-13 2010-01-05 Bristol-Myers Squibb Company Modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
JP2011231081A (ja) * 2010-04-30 2011-11-17 Kawasaki Kasei Chem Ltd ９，１０−ジヒドロ−９，１０−エタノアントラセン−９，１０−ジオール化合物及びその製造方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR6317M (es) * 1967-09-06 1968-09-16
CA1056842A (en) * 1975-06-12 1979-06-19 Masayuki Narisada Dihydroethanoanthracene derivatives

Also Published As

Publication number Publication date
IE902331A1 (en) 1991-01-16
ATE130296T1 (de) 1995-12-15
DK0405436T3 (da) 1995-12-11
EP0405436A3 (en) 1992-02-26
GR3018180T3 (en) 1996-02-29
EP0405436B1 (en) 1995-11-15
DE69023557T2 (de) 1996-05-02
EP0405436A2 (en) 1991-01-02
PT94513B (pt) 1997-02-28
IE902331L (en) 1990-12-29
JPH03115269A (ja) 1991-05-16
DE69023557D1 (de) 1995-12-21
PT94513A (pt) 1991-02-08
CA2019768A1 (en) 1990-12-29

Similar Documents

Publication Publication Date Title
ZA917744B (en) Fused ring analogs of nitrogen containing nonaromatic heterocycles.
ES2058614T3 (es) 1,2-ciclohexilaminoarilaminadas utiles como agentes analgesicos.
ES2062374T3 (es) Heteroarilpiperazinas, agentes antipsicoticos.
DK0655996T3 (da) Substituerede benzylamino-nitrogenholdige, ikke-aromatiske, heterocykliske forbindelser
SG47520A1 (en) New method for the production of 9-amino-6-demethyl-6-deoxytetracycline
ES2078922T3 (es) Derivados de cicloheteroetanoantraceno dihetero nitrogenados utiles como agentes antipsicoticos.
DK183789A (da) 2-alkyl-3-benzoylbenzofuraner og laegemidler indeholdende disse
EP0328634A4 (en) Pharmaceutical compositions for the treatment of psoriasis
NZ238238A (en) 5h,10h-pyrido(3,4-b)pyrrolo(1,2-e)(1,4,5)oxadiazepine derivatives and pharmaceutical compositions thereof having analgesic activity
ES2102774T3 (es) Indolsulfonamidas como agentes antitumorales.
FI902851A0 (fi) 4,5,5a,6-tetrahydro-3h-isoxazolo/5,4,3 -kl/akridinderivat, foerfarande foer deras framstaellande och deras anvaendning som laekemedel.
ATE17244T1 (de) Biologisch wirksame, heterobicyclische hydroximidate und thiolhydroximidate und deren carbamatester-derivate.
TH11701EX (th) สารประกอบเฮเทโรไซคลิคที่ใช้ในการรักษาโรค

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 405436

Country of ref document: ES